Company Profile

Discover and develop the best medicine to serve patients

View More
Zenshine Pharmaceuticals Co., Ltd. was founded in 2018 by industry veterans with a track-record of successful drug discovery and development. Headquartered in Nanjing, China, Zenshine’s discovery research operation is based in Hangzhou, China and its clinical management and business development have a presence in the San Francisco bay area, USA.
Our Pipeline

Zenshine’s drug discovery and development programs involve targeting purinergic signaling in immune cells and intracellular signal transduction pathways to modulate tumor microenvironment and thus to promote immunity. Oncology - targeting cancer intrinsic and extrinsic characteristics by either directly blocking tumor growth or modulating tumor microenvironment. Anti-infection - targeting pathogen infection that threats public health.

View More
View All
NDA filing accepted by NMPA for Seloxavir Marboxil of Zenshine pharma’s Class 1 New Drug
View More
Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults
View More
First Patient Dosed in a Phase 3 Clinical Study of ZX-7101A for the Treatment of Uncomplicated Influenza
View More